Arm Holdings plc (ARM) financials
NASDAQ · Technology · Semiconductors · 9,584 employees · CEO Rene Anthony Andrada Haas
- Price
- $205.97 -9.97%
- Market cap
- $219B
- Enterprise value
- $217B
- Last report
- Q1 '27 filed 2026-07-29
- Next report
- 2026-11-04 EPS est. $0.48
Valuation & key figures
- Market cap
- $219B EV $217B
- Revenue
- $5.16B Trailing 12 months
- Revenue growth
- +24% FY2027 consensus
- Profit margin
- 20.2% Net income / revenue, TTM
- P/E
- 212.3× Forward 93.4× (FY2027)
- P/S
- 42.5× Price / sales, TTM
- EV / EBITDA
- 157.7× TTM
- Free cash flow
- $1.47B Trailing 12 months
- Net income
- $1.04B Trailing 12 months
- Revenue estimate
- $6.09B FY2027 consensus
- Earnings
- 2026-11-04 Revenue est. $1.38B
- Dividend
- – No dividend
Key takeaways
Computed from the reported numbers - every statement carries the figure it rests on.
- Last report (2026-07-29): revenue beat by 2.1%, EPS beat by 12.5%Revenue $1.29B vs $1.26B expected (+2.1%); EPS $0.45 vs $0.40 (+12.5%).
- Revenue growth steady: 22.4% year on yearQ1 '27 revenue $1.29B, against an average of 23.3% over the four quarters before.
- Operating margin 17.3% (TTM), -1.0 pp on a year agoOperating income grew 18.0% while revenue grew 25.1%.
- 29.4% of pre-tax profit is non-operatingPre-tax income $1.26B vs operating income $892M (TTM). Gains on equity stakes and other one-off items lift net income and EPS - operating income is the cleaner measure of the business.
- Capex 12.0% of revenue (a year ago 8.8%)$620M invested in the last 4 quarters (+71.3% on a year earlier). Free cash flow $1.47B = 141.2% of net income.
- Returned $202M to shareholders = 13.7% of free cash flowBuybacks $202M (a year earlier $85M), dividends $0, stock-based pay $1.15B (TTM).
- Diluted share count up 1.2% in a year1.08B diluted shares in Q1 '27, 1.07B a year earlier.
- Net cash $3.4BCash + short-term investments $3.89B, debt incl. leases $485M; a year ago net cash $2.51B.
Last quarter: Q1 '27
Quarter ended 2026-06-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.
Quarter vs a year ago
| Q1 '27 | Year ago | Change | |
|---|---|---|---|
| Revenue | $1.29B | $1.05B | +22.4% |
| Gross margin | 97.2% | 94.3% | +2.9 pp |
| Operating income | $98M | $107M | -8.4% |
| Operating margin | 7.6% | 10.2% | -2.6 pp |
| Net income | $270M | $130M | +107.7% |
| Diluted EPS | $0.25 | $0.12 | +108.3% |
| Operating cash flow | $902M | $332M | +171.7% |
| Capex | $208M | $161M | +29.2% |
| Free cash flow | $694M | $171M | +305.8% |
| R&D | $838M | $654M | +28.1% |
| Stock-based compensation | $343M | $241M | +42.3% |
Reported vs consensus
2026-07-29| Actual | Consensus | vs consensus | |
|---|---|---|---|
| Revenue | $1.29B | $1.26B | +2.1% |
| EPS (as estimated) | $0.45 | $0.40 | +12.5% |
From the report of 2026-07-29 for Q1 '27: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.
EPS vs consensus
last 8 reportsRevenue
Where the money comes from - by business line and by region, quarter by quarter.
Revenue, operating income and growth
quarterlyMargins & cost structure
How much of each unit of revenue is left at each level - and where the costs go.
Margins
quarterlyCosts as % of revenue
quarterlyCash flow & capital allocation
Cash generated, what it is spent on, and what reaches shareholders.
Operating cash flow, capex, free cash flow
quarterlyUses of cash vs operating cash flow
fiscal yearsLast 4 quarters
cash flow statement- Operating cash flow
- $2.09B
- Capex
- -$620M
- Buybacks
- -$202M
- Dividends
- $0
- Acquisitions
- $45M
- Net debt issued
- $0
- Stock-based compensation
- $1.15B
- Free cash flow
- $1.47B
- Returned to shareholders / FCF
- 13.7%
Share count and EPS
quarterly, dilutedBalance sheet
Liquidity, investments and debt at each quarter end.
Cash, investments and debt
quarter endsValuation & returns
Today's multiples against the company's own last five fiscal years; analyst targets and ratings.
Multiples and returns
TTM vs 5 fiscal years| Now | 5y average | Where today sits in the 5-year range | |
|---|---|---|---|
| P/E (TTM) | 212.3× | 195.0× | 112.5× – 423.0× |
| EV / EBITDA | 157.7× | 162.9× 4 of 5 years | 72.5× – 344.1× |
| EV / Sales | 42.0× | 30.6× 4 of 5 years | 22.8× – 39.8× |
| Price / FCF | 148.7× | 238.2× | 96.5× – 629.9× |
| Price / Book | 25.4× | 18.9× 4 of 5 years | 15.4× – 24.6× |
| FCF yield | 0.7% | 0.6% | 0.2% – 1.0% |
| Return on invested capital | 7.3% | 5.7% | 0.0% – 10.3% |
| Return on equity | 13.0% | 8.2% | 0.0% – 12.9% |
Analysts
Consensus target $375.92 (+82.5%)
range $250.00 – $641.00 · rating Buy
Outlook
Analyst consensus for the coming fiscal years and what it implies at today's price.
Consensus estimates
| Fiscal year | Revenue | Growth | EPS | Growth | P/E at today's price | Analysts (EPS) |
|---|---|---|---|---|---|---|
| FY2027 | $6.09B | +23.8% | $2.21 | +159.4% | 93.4× | 19 |
| FY2028 | $8.3B | +36.4% | $3.02 | +37.0% | 68.2× | 24 |
| FY2029 | $10.8B | +30.3% | $3.92 | +29.8% | 52.5× | 11 |
| FY2030 | $16.4B | +51.5% | $6.34 | +61.9% | 32.5× | 11 |
| FY2031 | $27.3B | +66.6% | $10.05 | +58.4% | 20.5× | 18 |
Financial statements
Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.
Sources
Statements, segment revenue, metrics and estimates: Financial Modeling Prep.
Data as of 2026-11-01